e1 id: E116; e2 id: E113; e1 text: dural and , likely , leptomeningeal enhancement; e2 text: head MRI
ground truth: BEFORE; prediction: AFTER

e1 id: E109; e2 id: T7; e1 text: a new right-sided ptosis; e2 text: November 20
ground truth: AFTER; prediction: BEFORE

e1 id: E112; e2 id: E109; e1 text: febrile; e2 text: a new right-sided ptosis
ground truth: OVERLAP; prediction: AFTER

e1 id: E68; e2 id: E69; e1 text: Cellcept; e2 text: infection
ground truth: BEFORE; prediction: AFTER

e1 id: E57; e2 id: E55; e1 text: previous baseline creatinine; e2 text: acute renal failure
ground truth: BEFORE; prediction: OVERLAP

e1 id: E187; e2 id: E158; e1 text: creatinine; e2 text: discharge
ground truth: BEFORE; prediction: AFTER

e1 id: E61; e2 id: E187; e1 text: peak creatinine; e2 text: creatinine
ground truth: BEFORE; prediction: OVERLAP

e1 id: E58; e2 id: E55; e1 text: Kayexalate; e2 text: acute renal failure
ground truth: OVERLAP; prediction: AFTER

e1 id: E62; e2 id: E187; e1 text: discharge creatinine; e2 text: creatinine
ground truth: OVERLAP; prediction: AFTER

e1 id: E213; e2 id: E122; e1 text: progressive Acanthamoeba infection; e2 text: fevers
ground truth: BEFORE; prediction: OVERLAP

e1 id: E145; e2 id: E144; e1 text: pain; e2 text: morphine
ground truth: BEFORE; prediction: OVERLAP

e1 id: E146; e2 id: E144; e1 text: air hunger; e2 text: morphine
ground truth: BEFORE; prediction: OVERLAP

e1 id: E148; e2 id: E147; e1 text: congestion; e2 text: sinus suctioning
ground truth: BEFORE; prediction: OVERLAP

e1 id: E149; e2 id: E147; e1 text: nasal sprays; e2 text: sinus suctioning
ground truth: OVERLAP; prediction: BEFORE

e1 id: E156; e2 id: T5; e1 text: hospitalized; e2 text: November 11
ground truth: BEFORE; prediction: OVERLAP

e1 id: E156; e2 id: T4; e1 text: hospitalized; e2 text: September 26
ground truth: AFTER; prediction: OVERLAP

e1 id: E31; e2 id: E156; e1 text: head CT; e2 text: hospitalized
ground truth: OVERLAP; prediction: AFTER

e1 id: E32; e2 id: E156; e1 text: MRI; e2 text: hospitalized
ground truth: OVERLAP; prediction: AFTER

e1 id: E226; e2 id: E152; e1 text: inflammation; e2 text: prednisone
ground truth: BEFORE; prediction: OVERLAP

e1 id: E227; e2 id: E152; e1 text: adrenal insufficiency; e2 text: prednisone
ground truth: BEFORE; prediction: OVERLAP

e1 id: E228; e2 id: T9; e1 text: comfortable; e2 text: December 3
ground truth: BEFORE; prediction: OVERLAP

e1 id: E211; e2 id: E118; e1 text: cyclosporine; e2 text: cyclosporine
ground truth: OVERLAP; prediction: BEFORE

e1 id: E201; e2 id: E95; e1 text: CMV; e2 text: A repeat CMV hypercapture
ground truth: BEFORE; prediction: OVERLAP

e1 id: E55; e2 id: E53; e1 text: acute renal failure; e2 text: increasing ARS
ground truth: OVERLAP; prediction: AFTER

e1 id: E55; e2 id: E184; e1 text: acute renal failure; e2 text: stay
ground truth: OVERLAP; prediction: AFTER

e1 id: E186; e2 id: E157; e1 text: hemodialysis; e2 text: stay
ground truth: OVERLAP; prediction: AFTER

e1 id: E219; e2 id: E217; e1 text: Pentamidine; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E220; e2 id: E217; e1 text: itraconazole; e2 text: a family meeting
ground truth: BEFORE; prediction: AFTER

e1 id: E221; e2 id: E217; e1 text: Levaquin; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E222; e2 id: E217; e1 text: acyclovir; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E223; e2 id: E217; e1 text: GCSF; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E224; e2 id: E217; e1 text: other medications; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E2; e2 id: E163; e1 text: ARS; e2 text: admission
ground truth: BEFORE; prediction: AFTER

e1 id: T0; e2 id: E1; e1 text: nine months; e2 text: non-myeloblative stem cell transplant
ground truth: AFTER; prediction: OVERLAP

e1 id: E43; e2 id: E53; e1 text: increasing ARS; e2 text: increasing ARS
ground truth: OVERLAP; prediction: BEFORE

e1 id: E94; e2 id: E93; e1 text: coagulase negative Staphylococcus; e2 text: a blood culture
ground truth: BEFORE; prediction: OVERLAP

e1 id: E12; e2 id: T12; e1 text: Rituxan; e2 text: November , 2001
ground truth: OVERLAP; prediction: AFTER

e1 id: E143; e2 id: E217; e1 text: aggressive measures of care; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E207; e2 id: E204; e1 text: Infectious disease consult; e2 text: admission
ground truth: AFTER; prediction: OVERLAP

e1 id: E205; e2 id: T18; e1 text: erythematous nodules over both arms; e2 text: the days
ground truth: OVERLAP; prediction: BEFORE

e1 id: E189; e2 id: E72; e1 text: DSCI clinic; e2 text: rehabilitation
ground truth: OVERLAP; prediction: AFTER

e1 id: E24; e2 id: E23; e1 text: recurrent fever; e2 text: Campath
ground truth: OVERLAP; prediction: BEFORE

e1 id: E47; e2 id: E39; e1 text: re-CT of sinuses; e2 text: itraconazole
ground truth: AFTER; prediction: OVERLAP

e1 id: E41; e2 id: E39; e1 text: continued neutropenia; e2 text: itraconazole
ground truth: OVERLAP; prediction: BEFORE

e1 id: E42; e2 id: E40; e1 text: sulfadiazine; e2 text: voriconazole
ground truth: OVERLAP; prediction: BEFORE

e1 id: E87; e2 id: E87; e1 text: Workup on admission; e2 text: Workup on admission
ground truth: AFTER; prediction: OVERLAP
This relation involves in BBB

e1 id: E198; e2 id: E90; e1 text: abscess; e2 text: an MRI of the liver
ground truth: BEFORE; prediction: OVERLAP

e1 id: E92; e2 id: E87; e1 text: Blood and urine cultures; e2 text: Workup on admission
ground truth: AFTER; prediction: OVERLAP
This relation involves in BBB

e1 id: E49; e2 id: E50; e1 text: recurrent CMB infection; e2 text: Campath therapy
ground truth: OVERLAP; prediction: AFTER

e1 id: E53; e2 id: E183; e1 text: increasing ARS; e2 text: inability to tolerate
ground truth: OVERLAP; prediction: BEFORE

e1 id: E127; e2 id: E124; e1 text: a PICC line; e2 text: A single blood culture
ground truth: BEFORE; prediction: AFTER

e1 id: E135; e2 id: E123; e1 text: all above measures; e2 text: maximal antimicrobial therapy
ground truth: OVERLAP; prediction: AFTER

e1 id: E108; e2 id: E102; e1 text: maximal antimicrobial therapy; e2 text: voriconazole
ground truth: OVERLAP; prediction: AFTER

e1 id: E15; e2 id: E14; e1 text: lymphopenia; e2 text: Campath
ground truth: OVERLAP; prediction: BEFORE

e1 id: E16; e2 id: E14; e1 text: neutropenia; e2 text: Campath
ground truth: OVERLAP; prediction: BEFORE

e1 id: E85; e2 id: E160; e1 text: treatment; e2 text: admitted
ground truth: AFTER; prediction: OVERLAP

e1 id: E6; e2 id: E173; e1 text: cervical lymphadenopathy; e2 text: presented
ground truth: BEFORE; prediction: OVERLAP

e1 id: E174; e2 id: E8; e1 text: did well; e2 text: CytaBOM
ground truth: AFTER; prediction: BEFORE

e1 id: E7; e2 id: T10; e1 text: MACE; e2 text: 1991
ground truth: OVERLAP; prediction: AFTER

e1 id: E8; e2 id: E7; e1 text: CytaBOM; e2 text: MACE
ground truth: OVERLAP; prediction: BEFORE

e1 id: T11; e2 id: E9; e1 text: six cycles; e2 text: fludarabine
ground truth: OVERLAP; prediction: BEFORE

e1 id: E9; e2 id: T2; e1 text: fludarabine; e2 text: 1997
ground truth: OVERLAP; prediction: BEFORE

e1 id: E102; e2 id: E207; e1 text: voriconazole; e2 text: Infectious disease consult
ground truth: BEFORE; prediction: AFTER

e1 id: E106; e2 id: E204; e1 text: Pentamidine intravenous and nasal washings; e2 text: admission
ground truth: BEFORE; prediction: AFTER

e1 id: E104; e2 id: E102; e1 text: treatment; e2 text: voriconazole
ground truth: OVERLAP; prediction: AFTER

